About the Personalized Immunotherapy Session
Personalized immunotherapy is revolutionizing cancer treatment by tailoring therapies to individual patients' immune systems and tumor characteristics. This approach harnesses the body's immune response to specifically target and destroy cancer cells while minimizing damage to healthy tissue. By analyzing the genetic makeup of tumors and the immune profiles of patients, researchers can develop personalized treatments such as immune checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines. These therapies offer the potential for more effective and durable responses compared to traditional treatments like chemotherapy and radiation. With ongoing advancements in technology and understanding of the immune system, personalized immunotherapy holds promise for improving outcomes and quality of life for cancer patients in the future.
Topics Covered in Personalized Immunotherapy
Neoantigen Prediction
Tumor Mutational Burden
Immune Profiling
Adoptive Cell Therapy
Individualized Vaccines
Resistance Mechanisms
Related Scientific Sessions at CIOC 2027
Why Attend the Personalized Immunotherapy Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Personalized Immunotherapy work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Personalized Immunotherapy research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Personalized Immunotherapy track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Personalized Immunotherapy Conference 2027 — FAQs
What is the Personalized Immunotherapy track at CIOC 2027?
The Personalized Immunotherapy track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Personalized Immunotherapy. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Personalized Immunotherapy sessions?
Cancer researchers and clinicians, educators and students with an interest in Personalized Immunotherapy are all welcome — whether presenting or attending.
Can I present my research in the Personalized Immunotherapy track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Personalized Immunotherapy sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Personalized Immunotherapy track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.